InvestorsHub Logo

itwillgetbetter

09/30/14 2:13 PM

#16700 RE: James salmon #16698

Well we already knew that.He has rights to Intellect.Now that he is a competitor Cerespir how long will that work is my point.

If he was working on something not related to ILNS then no problem but he is going to be doing research regarding A/D and I wish him well and hope he succeeds.Maybe he wins the Nobel award just wish it was at Intellect.


Well the VPHM now Shire trial will now be ABBV before years end.Just keeps getting bigger.

http://blogs.wsj.com/pharmalot/2014/09/30/abbvie-ceo-tells-employees-that-shire-deal-is-going-through/?mod=yahoo_hs